Effects of dietary supplements on induction and inhibition of cytochrome P450s protein expression in rats

被引:22
|
作者
Jang, EH
Park, YC
Chung, WG
机构
[1] Inha Univ, Coll Med, Dept Pharmacol & Toxicol, Inchon 402751, South Korea
[2] Catholic Univ Daegu, Inst Nat Sci, Kyongbuk, South Korea
关键词
herbal dietary supplements; CYP1A2; CYP2C; CYP2E1; CYP3A; CYP2D1; induction; inhibition; drug interactions;
D O I
10.1016/j.fct.2004.07.001
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Recent surveys show that 18% of adults in the United States use prescription drugs concurrently with herbal or vitamin dietary products. Despite possible dietary supplement-drug interactions through modulation of cytochrome P450s (CYPs), dietary supplements have not been studied at a screening scale to assess their effects on CYPs. In this study, 116 herbal dietary supplements, commercially available for nutrient supply and weight management, were administered to rats to test whether they modulate the expressions of CYP1A2, 2C11, 2D1, 2E1 and 3A1 proteins. Seventy-five percent of the 116 dietary supplements modulated at least one CYP, while 25% had no effect. CYP2C11 protein expression was the most inhibited by supplements (51%), whereas CYP1A2, 2D1, 2E1 and 3A1 were the least inhibited (12-18%). CYP1A2 was the most induced, modulated by 21% Supplements, while CYP2E1 and 3A1 were moderately induced (7-8%). CYP2C11 and 2D1 were not induced by any supplement tested in this study. Thus, this study suggests that dietary supplement-drug interactions may occur through modulation of CYPs in humans when they are taken simultaneously. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1749 / 1756
页数:8
相关论文
共 50 条
  • [31] The ins and outs of cytochrome P450s
    Cojocaru, Vlad
    Winn, Peter J.
    Wade, Rebecca C.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2007, 1770 (03): : 390 - 401
  • [32] Functions of minor cytochrome P450s
    Ingelman-Sundberg, Magnus
    DRUG METABOLISM REVIEWS, 2006, 38 : 4 - 5
  • [33] Interactions of cytochrome P450s with their ligands
    Conner, Kip P.
    Woods, Caleb M.
    Atkins, William M.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2011, 507 (01) : 56 - 65
  • [34] SUBSTRATE RECOGNITION BY CYTOCHROME P450S
    Scott, Emily E.
    Bart, Aaron G.
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S11 - S12
  • [35] Cytochrome P450s and cholesterol homeostasis
    Pikuleva, Irina A.
    PHARMACOLOGY & THERAPEUTICS, 2006, 112 (03) : 761 - 773
  • [36] Cytochrome P450s in Lignin Biosynthesis
    Alber, Annette
    Ehlting, Juergen
    LIGNINS: BIOSYNTHESIS, BIODEGRADATION AND BIOENGINEERING, 2012, 61 : 113 - 143
  • [37] The cytochrome P450s and "reactive metabolites"
    Estabrook, RW
    TOXICOLOGY, 2002, 178 (01) : 6 - 7
  • [38] EFFECTS OF PHENOL RED ON RIFAMPICIN-INDUCED EXPRESSION OF CYTOCHROME P450S ENZYMES
    Kuncharoenwirat, Nathaphon
    Chatuphonprasert, Waranya
    Jarukamjorn, Kanokwan
    PHARMACOPHORE, 2020, 11 (03): : 13 - 20
  • [39] DOES SELECTIVE-INHIBITION OF CYTOCHROME P450S OCCUR WITH AGING
    KINIRONS, MT
    MORIKE, K
    SHAY, S
    RODEN, DM
    WOOD, AJJ
    CLINICAL RESEARCH, 1994, 42 (02): : A215 - A215
  • [40] Effects of Acetylenic Epoxygenase Inhibitors on Recombinant Cytochrome P450s
    VanAlstine, Melissa A.
    Hough, Lindsay B.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (07) : 1221 - 1226